Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma

Ibrutinib has demonstrated high response rates in B-cell lymphomas but a lot of ibrutinib-treated patients relapse with resistance. This study unified TME-mediatedde novoand acquired drug resistance through B-cell receptor signalling and PI3K-AKT-mTOR axis and provides a combination therapeutic stra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiaohong Zhao, Tint Lwin, Ariosto Silva, Bijal Shah, Jiangchuan Tao, Bin Fang, Liang Zhang, Kai Fu, Chengfeng Bi, Jiannong Li, Huijuan Jiang, Mark B. Meads, Timothy Jacobson, Maria Silva, Allison Distler, Lancia Darville, Ling Zhang, Ying Han, Dmitri Rebatchouk, Maurizio Di Liberto, Lynn C. Moscinski, John M. Koomen, William S. Dalton, Kenneth H. Shain, Michael Wang, Eduardo Sotomayor, Jianguo Tao
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/87b74c23a81c4b28a5b297ad5bef630b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:87b74c23a81c4b28a5b297ad5bef630b
record_format dspace
spelling oai:doaj.org-article:87b74c23a81c4b28a5b297ad5bef630b2021-12-02T14:41:10ZUnification of de novo and acquired ibrutinib resistance in mantle cell lymphoma10.1038/ncomms149202041-1723https://doaj.org/article/87b74c23a81c4b28a5b297ad5bef630b2017-04-01T00:00:00Zhttps://doi.org/10.1038/ncomms14920https://doaj.org/toc/2041-1723Ibrutinib has demonstrated high response rates in B-cell lymphomas but a lot of ibrutinib-treated patients relapse with resistance. This study unified TME-mediatedde novoand acquired drug resistance through B-cell receptor signalling and PI3K-AKT-mTOR axis and provides a combination therapeutic strategy against B-cell malignancies.Xiaohong ZhaoTint LwinAriosto SilvaBijal ShahJiangchuan TaoBin FangLiang ZhangKai FuChengfeng BiJiannong LiHuijuan JiangMark B. MeadsTimothy JacobsonMaria SilvaAllison DistlerLancia DarvilleLing ZhangYing HanDmitri RebatchoukMaurizio Di LibertoLynn C. MoscinskiJohn M. KoomenWilliam S. DaltonKenneth H. ShainMichael WangEduardo SotomayorJianguo TaoNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-15 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Xiaohong Zhao
Tint Lwin
Ariosto Silva
Bijal Shah
Jiangchuan Tao
Bin Fang
Liang Zhang
Kai Fu
Chengfeng Bi
Jiannong Li
Huijuan Jiang
Mark B. Meads
Timothy Jacobson
Maria Silva
Allison Distler
Lancia Darville
Ling Zhang
Ying Han
Dmitri Rebatchouk
Maurizio Di Liberto
Lynn C. Moscinski
John M. Koomen
William S. Dalton
Kenneth H. Shain
Michael Wang
Eduardo Sotomayor
Jianguo Tao
Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
description Ibrutinib has demonstrated high response rates in B-cell lymphomas but a lot of ibrutinib-treated patients relapse with resistance. This study unified TME-mediatedde novoand acquired drug resistance through B-cell receptor signalling and PI3K-AKT-mTOR axis and provides a combination therapeutic strategy against B-cell malignancies.
format article
author Xiaohong Zhao
Tint Lwin
Ariosto Silva
Bijal Shah
Jiangchuan Tao
Bin Fang
Liang Zhang
Kai Fu
Chengfeng Bi
Jiannong Li
Huijuan Jiang
Mark B. Meads
Timothy Jacobson
Maria Silva
Allison Distler
Lancia Darville
Ling Zhang
Ying Han
Dmitri Rebatchouk
Maurizio Di Liberto
Lynn C. Moscinski
John M. Koomen
William S. Dalton
Kenneth H. Shain
Michael Wang
Eduardo Sotomayor
Jianguo Tao
author_facet Xiaohong Zhao
Tint Lwin
Ariosto Silva
Bijal Shah
Jiangchuan Tao
Bin Fang
Liang Zhang
Kai Fu
Chengfeng Bi
Jiannong Li
Huijuan Jiang
Mark B. Meads
Timothy Jacobson
Maria Silva
Allison Distler
Lancia Darville
Ling Zhang
Ying Han
Dmitri Rebatchouk
Maurizio Di Liberto
Lynn C. Moscinski
John M. Koomen
William S. Dalton
Kenneth H. Shain
Michael Wang
Eduardo Sotomayor
Jianguo Tao
author_sort Xiaohong Zhao
title Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
title_short Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
title_full Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
title_fullStr Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
title_full_unstemmed Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
title_sort unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/87b74c23a81c4b28a5b297ad5bef630b
work_keys_str_mv AT xiaohongzhao unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT tintlwin unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT ariostosilva unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT bijalshah unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT jiangchuantao unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT binfang unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT liangzhang unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT kaifu unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT chengfengbi unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT jiannongli unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT huijuanjiang unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT markbmeads unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT timothyjacobson unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT mariasilva unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT allisondistler unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT lanciadarville unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT lingzhang unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT yinghan unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT dmitrirebatchouk unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT mauriziodiliberto unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT lynncmoscinski unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT johnmkoomen unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT williamsdalton unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT kennethhshain unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT michaelwang unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT eduardosotomayor unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
AT jianguotao unificationofdenovoandacquiredibrutinibresistanceinmantlecelllymphoma
_version_ 1718390003956973568